| 1 |
Spezia PG, Focosi D, Baj A, et al. TTV and other anelloviruses: the astonishingly wide spread of a viral infection[J]. Asp Mol Med, 2023,1:None.
|
| 2 |
Focosi D, Spezia PG, Macera L, et al. Assessment of prevalence and load of torquetenovirus viraemia in a large cohort of healthy blood donors[J]. Clin Microbiol Infect, 2020,26(10):1406-1410.
|
| 3 |
Jaksch P, Görzer I, Puchhammer-Stöckl E, et al. Integrated immunologic monitoring in solid organ transplantation: the road toward torque teno virus-guided immunosuppression[J]. Transplantation, 2022,106(10):1940-1951.
|
| 4 |
Kuczaj A, Przybyłowski P, Hrapkowicz T. Torque teno virus (TTV)-a potential marker of immunocompetence in solid organ recipients[J]. Viruses, 2023,16(1):17.
|
| 5 |
Zeng J, Tang Y, Lin T, et al. Torque-teno virus for the prediction of graft rejection and infection disease after kidney transplantation: a systematic review and meta-analysis[J]. J Med Virol, 2023,95(3):e28677.
|
| 6 |
Rezahosseini O, Drabe CH, Sørensen SS, et al. Torque-Teno virus viral load as a potential endogenous marker of immune function in solid organ transplantation[J]. Transplant Rev (Orlando), 2019,33(3):137-144.
|
| 7 |
van Rijn AL, Roos R, Dekker FW, et al. Torque teno virus load as marker of rejection and infection in solid organ transplantation - A systematic review and meta-analysis[J]. Rev Med Virol, 2023,33(1):e2393.
|
| 8 |
Kulifaj D, Durgueil-Lariviere B, Meynier F, et al. Development of a standardized real time PCR for Torque teno viruses (TTV) viral load detection and quantification: A new tool for immune monitoring[J]. J Clin Virol, 2018,105:118-127.
|
| 9 |
Focosi D, Antonelli G, Pistello M, et al. Torquetenovirus: the human virome from bench to bedside[J]. Clin Microbiol Infect, 2016,22(7):589-593.
|
| 10 |
Varsani A, Opriessnig T, Celer V, et al. Taxonomic update for mammalian anelloviruses (family Anelloviridae)[J]. Arch Virol, 2021,166(10): 2943-2953.
|
| 11 |
程实,范航,孙强,等. 我国人群感染指环病毒的高通量测序分析[J]. 中国病原生物学杂志,2016,11(10):865-870.
|
| 12 |
Maggi F, Fornai C, Vatteroni ML, et al. Low prevalence of TT virus in the cerebrospinal fluid of viremic patients with central nervous system disorders[J]. J Med Virol, 2001,65(2):418-422.
|
| 13 |
Ekberg H, Tedesco-Silva H, Demirbas A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation[J]. N Engl J Med, 2007,357(25): 2562-2575.
|
| 14 |
Vincenti F, Larsen C, Durrbach A, et al. Costimulation blockade with belatacept in renal transplantation[J]. N Engl J Med, 2005,353(8): 770-781.
|
| 15 |
Jaksch P, Kundi M, Görzer I, et al. Torque teno virus as a novel biomarker targeting the efficacy of immunosuppression after lung transplantation[J]. J Infect Dis, 2018,218(12):1922-1928.
|
| 16 |
Mankotia DS, Irshad M. Development of an immunoassay for detection of Torque Teno Virus (TTV) antibodies using the N22 expression product from TTV genotype 2[J]. Intervirology, 2017, 60(5): 207-216.
|
| 17 |
Hino S, Miyata H. Torque teno virus (TTV): current status[J]. Rev Med Virol, 2007, 17(1): 45-57.
|
| 18 |
Davis JS, Chu G, Pathinayake P, et al. Seroprevalence of torque teno virus in hemodialysis and renal transplant patients in Australia: a cross-sectional study[J]. Transpl Infect Dis, 2020,22(5):e13400.
|